Work by MedImmune scientists in the Cambridge UK medical technology cluster has contributed to the development of a potential new treatment for severe asthma. Read more...
Medical technology company iSonea Limited has signed an agreement with TREMOR, a division of global consumer brand leader Procter & Gamble , aiming to promote AirSonea to women with asthma and mothers ...
A list released on October 28th, identified five commonly performed tests and procedures in pulmonary medicine that may not always be necessary. The list, part of the ABIM Foundation's Choosing Wisely® campaign, was produced by a collaborative task force assembled by the American Thoracic Society (ATS) and the American College of Chest Physicians (ACCP).
- Phase III of Windward begins
Numab AG a company focused on the discovery and development of innovative antibody-based therapeutics announced today that it has reacquired the rights to ND003 a bispecific anti-IL5RxCD3 antibody fragment for the targeted lysis of eosinophils in severe asthma from Sucampo AG a subsidiary of Sucampo Pharmaceuticals Inc. (Nasdaq:SCMP).
Numab AG, a company focused on the discovery and development of innovative antibody-based therapeutics, announced today that it has reacquired the rights to ND003, a bispecific anti-IL5RxCD3 antibody fragment for the targeted lysis of eosinophils in severe asthma, from Sucampo AG, a subsidiary of Sucampo Pharmaceuticals, Inc.
New research from Japan brings hope of a new treatment for asthma patients resistant to corticosteroids.
Obstructive sleep apnea is known to be associated with an increased incidence of cardiovascular disease. Now a new study indicates that OSA is associated with subclinical myocardial injury, as indicated by increased high sensitivity troponin T (hs-TnT) levels. Elevated hs-TnT levels are predictive of both coronary heart disease (CHD) and heart failure (HF) in the general population.
Regulatory T cells (Tregs) function to suppress immune responses of other cells, and their dysfunction has been associated with development of immune disorders. Recent studies suggest that Tregs maintain plasticity even after differentiation, and can be influenced to change their regulatory profile.
Any A&E doctor will tell you the revolving doors really start spinning after midnight as patients with severe issues start being admitted to hospital.